Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being investigated for type 2 diabetes treatment. Our facility produces high-purity tirzepatide with strict quality control measures to ensure research-grade material.
This compound demonstrates superior efficacy in glucose control and weight loss compared to similar agents. As a dual agonist, tirzepatide exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity, resulting in enhanced glycemic control.
Our tirzepatide is supplied as a white powder with purity exceeding 98% (confirmed by HPLC analysis). The product is stable when stored properly and suitable for various research applications.
Key advantages of our tirzepatide include:
- Manufactured under cGMP conditions
- Rigorous quality testing
- Bulk quantities for research institutions
Note: This product is for research use only. Not for human consumption or diagnostic use.